Covid-19, FDA and vaccines
Digest more
Top News
Overview
Impacts
6h
CNET on MSNThe FDA Warns of New Zyrtec and Xyzal Side Effect. Here's What We Know About Treating ItIf you've been taking Zyrtec or Xyzal for your worsening allergy symptoms, there's a new side effect you should know about.
The U.S. Food and Drug Administration is warning that certain half-shell oysters that are frozen and raw harvested in South Korea may be potentially contaminated with norovirus.
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound).
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this fall and winter.
Explore more
1d
MedPage Today on MSNFDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes acrimonious questions from Senators about agency staffing cuts, limits on COVID boosters, and more.
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.
By Stephanie Brown HealthDay ReporterFRIDAY, May 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).
The unusually high rate of adverse events identified in the report, he noted, “indicates that at very least, the label should be changed.” In other words, the top U.S. health official is prepared to rework—based at least in part on a poorly designed report that has not undergone scientific review—the government’s official guidance on a widely used drug.